{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:23:09Z","timestamp":1793067789723,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Pathogenesis and Therapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.cpt.2024.04.004","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T12:32:14Z","timestamp":1714048334000},"page":"101-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Cardiotoxicity in platinum-based chemotherapy: Mechanisms, manifestations, and management"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5737-2655","authenticated-orcid":false,"given":"Betty","family":"Rachma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merlyna","family":"Savitri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5730-2013","authenticated-orcid":false,"given":"Henry","family":"Sutanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpt.2024.04.004_bib1","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1517\/14656566.4.6.889","article-title":"Toxicity of platinum compounds","volume":"4","author":"Hartmann","year":"2003","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.cpt.2024.04.004_bib2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bpobgyn.2016.11.004","article-title":"Chemotherapy for epithelial ovarian, fallopian tube and primary peritoneal cancer","volume":"41","author":"Webber","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.cpt.2024.04.004_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/j.seminoncol.2004.11.007","article-title":"Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers","volume":"31","author":"Muggia","year":"2004","journal-title":"Semin Oncol"},{"key":"10.1016\/j.cpt.2024.04.004_bib4","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1002\/jcp.26091","article-title":"Genetic variation in the DNA repair pathway as a potential determinant of response to platinum-based chemotherapy in breast cancer","volume":"233","author":"Beheshti","year":"2018","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.cpt.2024.04.004_bib5","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1111\/1759-7714.13683","article-title":"Genetic variants as predictors of toxicity and response in patients with non-small cell lung cancer undergoing first-line platinum-based chemotherapy: design of the multicenter PGxLUNG study","volume":"11","author":"Jong de","year":"2020","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.cpt.2024.04.004_bib6","first-page":"150","article-title":"Research advances in resistance to platinum-based chemotherapy in lung cancer","volume":"39","author":"Zhang","year":"2017","journal-title":"Acta Academiae Medicinae Sinicae"},{"key":"10.1016\/j.cpt.2024.04.004_bib7","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.2459\/JCM.0000000000000376","article-title":"Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy","volume":"17","author":"Madeddu","year":"2016","journal-title":"J\u00a0Cardiovasc Med"},{"key":"10.1016\/j.cpt.2024.04.004_bib8","first-page":"34","article-title":"Cisplatin, environmental metals, and cardiovascular disease: an urgent need to understand underlying mechanisms","volume":"7","author":"Clasen","year":"2021","journal-title":"Cardiooncology"},{"key":"10.1016\/j.cpt.2024.04.004_bib9","doi-asserted-by":"crossref","DOI":"10.15275\/rusomj.2020.0305","article-title":"Pathophysiological mechanisms of cardiotoxicity in chemotherapeutic agents","volume":"9","author":"Chaulin","year":"2020","journal-title":"Russ Open Med J"},{"key":"10.1016\/j.cpt.2024.04.004_bib10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bcp.2015.08.101","article-title":"Silencing of PKC-\u03b1, TRPC1 or NF-\u03baB expression attenuates cisplatin-induced ICAM-1 expression and endothelial dysfunction","volume":"98","author":"Bodiga","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cpt.2024.04.004_bib11","first-page":"15","article-title":"Damage to cardiac vasculature may be associated with breast cancer treatment-induced cardiotoxicity","volume":"7","author":"Hoffman","year":"2021","journal-title":"Cardiooncology"},{"key":"10.1016\/j.cpt.2024.04.004_bib12","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1039\/C8DT00838H","article-title":"The side effects of platinum-based chemotherapy drugs: a review for chemists","volume":"47","author":"Oun","year":"2018","journal-title":"Dalton Trans"},{"key":"10.1016\/j.cpt.2024.04.004_bib13","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10495-008-0214-9","article-title":"Pravastatin attenuates carboplatin-induced cardiotoxicity via inhibition of oxidative stress associated apoptosis","volume":"13","author":"Cheng","year":"2008","journal-title":"Apoptosis"},{"key":"10.1016\/j.cpt.2024.04.004_bib14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.7150\/ijbs.49514","article-title":"Inhibition of PI3K\/AKT signaling via ROS regulation is involved in Rhein-induced apoptosis and enhancement of oxaliplatin sensitivity in pancreatic cancer cells","volume":"17","author":"Liu","year":"2021","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.cpt.2024.04.004_bib15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/10715762.2017.1313414","article-title":"Apelin-13 attenuates cisplatin-induced cardiotoxicity through inhibition of ROS-mediated DNA damage and regulation of MAPKs and AKT pathways","volume":"51","author":"Zhang","year":"2017","journal-title":"Free Radic Res"},{"key":"10.1016\/j.cpt.2024.04.004_bib16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00280-016-3045-3","article-title":"Mitochondria: inadvertent targets in chemotherapy-induced skeletal muscle toxicity and wasting?","volume":"78","author":"Sorensen","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.cpt.2024.04.004_bib17","article-title":"Oxaliplatin-induced cardiotoxicity in mice is connected to the changes in energy metabolism in the heart tissue","author":"Du","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.cpt.2024.04.004_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115587","article-title":"Regulation of the JAK\/STAT signaling pathway: the promising targets for cardiovascular disease","volume":"213","author":"Pang","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cpt.2024.04.004_bib19","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00280-018-3691-8","article-title":"Lactobacillus supplementation prevents cisplatin-induced cardiotoxicity possibly by inflammation inhibition","volume":"82","author":"Zhao","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.cpt.2024.04.004_bib20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.med.57.121304.131240","article-title":"Cardiotoxicity induced by chemotherapy and antibody therapy","volume":"57","author":"Yeh","year":"2006","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.cpt.2024.04.004_bib21","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.15420\/ecr.2022.63","article-title":"The 2022 European Society of Cardiology cardio-oncology guidelines in focus","volume":"18","author":"Gent","year":"2023","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.cpt.2024.04.004_bib22","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"ESC guidelines on cardio-oncology developed in collaboration with the European Hematology association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpt.2024.04.004_bib23","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013807","article-title":"Cisplatin-induced cardiotoxicity with midrange ejection fraction: a case report and review of the literature","volume":"97","author":"Hu","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.cpt.2024.04.004_bib24","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/life10120344","article-title":"Cardiotoxicity of novel targeted hematological therapies","volume":"10","author":"Giudice","year":"2020","journal-title":"Life"},{"key":"10.1016\/j.cpt.2024.04.004_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijcard.2014.04.238","article-title":"Cardiotoxicity: cisplatin and long-term cancer survivors","volume":"175","author":"Patan\u00e8","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cpt.2024.04.004_bib26","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.3892\/ol.2016.4195","article-title":"Bradycardia as a rare symptom of cisplatin cardiotoxicity: a case report","volume":"11","author":"Kucharz","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.cpt.2024.04.004_bib27","article-title":"Case report: oxaliplatin-induced third-degree atrioventricular block: first discovery of an important side-effect","volume":"9","author":"Chen","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cpt.2024.04.004_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/0036933019897347","article-title":"Cisplatin related cardiotoxicity \u2013 acute and chronic cardiovascular morbidity in a testicular cancer survivor","volume":"65","author":"Morrow","year":"2020","journal-title":"Scot Med J"},{"key":"10.1016\/j.cpt.2024.04.004_bib29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/ehjci\/jeaa289","article-title":"The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: a 30-year follow-up","volume":"22","author":"Bjerring","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.cpt.2024.04.004_bib30","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1007\/s00330-023-10420-w","article-title":"Long-term cardiotoxicity in germ cell cancer survivors after platinum-based chemotherapy: cardiac MR shows impaired systolic function and tissue alterations","volume":"34","author":"Beitzen-Heineke","year":"2024","journal-title":"Eur Radiol"},{"key":"10.1016\/j.cpt.2024.04.004_bib31","article-title":"FOLFOX induced takotsubo cardiomyopathy treated with Impella assist device","volume":"2017","author":"Sundaravel","year":"2017","journal-title":"Case Rep Cardiol"},{"key":"10.1016\/j.cpt.2024.04.004_bib32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1159\/000531389","article-title":"Oxaliplatin-associated takotsubo cardiomyopathy in a patient with metastatic gastric cancer: a case report","volume":"16","author":"Osorio-Toro","year":"2023","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.cpt.2024.04.004_bib33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.critrevonc.2013.02.007","article-title":"State of the art for cardiotoxicity due to chemotherapy and to targeted therapies: a literature review","volume":"88","author":"Berardi","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.cpt.2024.04.004_bib34","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.3390\/life13102103","article-title":"Multimodality cardiovascular imaging of cardiotoxicity due to cancer therapy","volume":"13","author":"Contaldi","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.cpt.2024.04.004_bib35","first-page":"372","article-title":"Cardiac biomarkers for the detection and management of cancer therapy-related cardiovascular toxicity","volume":"9","author":"Zhang","year":"2022","journal-title":"J\u00a0Cardiovasc Dev Dis"},{"key":"10.1016\/j.cpt.2024.04.004_bib36","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3390\/medicina57080806","article-title":"Cardiotoxicity associated with chemotherapy used in gastrointestinal tumours","volume":"57","author":"Radulescu","year":"2021","journal-title":"Medicina"},{"key":"10.1016\/j.cpt.2024.04.004_bib37","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10741-020-10028-y","article-title":"The role of cardiac magnetic resonance imaging in the detection and monitoring of cardiotoxicity in patients with breast cancer after treatment: a comprehensive review","volume":"26","author":"Jafari","year":"2021","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cpt.2024.04.004_bib38","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/echo.14944","article-title":"Role of myocardial strain imaging in surveillance and management of cancer therapeutics-related cardiac dysfunction: a systematic review","volume":"38","author":"McGregor","year":"2021","journal-title":"Echocardiography"},{"key":"10.1016\/j.cpt.2024.04.004_bib39","doi-asserted-by":"crossref","first-page":"511","DOI":"10.5507\/bp.2014.004","article-title":"Biomarkers for the early detection of anthracycline-induced cardiotoxicity: current status","volume":"158","author":"Horacek","year":"2014","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"10.1016\/j.cpt.2024.04.004_bib40","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.resp.2013.03.013","article-title":"Cardiotoxicity of cisplatin-based chemotherapy in advanced non-small cell lung cancer patients","volume":"187","author":"Demkow","year":"2013","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.cpt.2024.04.004_bib41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.20473\/fmi.v56i2.21205","article-title":"High sensitive troponin I and extended range C-reactive protein as markers to predict cardiotoxicity in locally advanced breast cancer with neoadjuvant CAF (cyclophoshpamide, adriamycin\/doxorubicin, 5fluorouracil) therapy","volume":"56","author":"Hidayat","year":"2020","journal-title":"Folia Medica Indonesiana"},{"key":"10.1016\/j.cpt.2024.04.004_bib42","first-page":"163","article-title":"High sensitivity troponin T as complementary modality for determining doxorubicin regimen cardiotoxicity in non-Hodgkin lymphoma patients","volume":"12","author":"Prayogo","year":"2022","journal-title":"Adv Pharmaceut Bull"},{"key":"10.1016\/j.cpt.2024.04.004_bib43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1179\/102453312X13376952196412","article-title":"Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in children","volume":"17","author":"Sherief","year":"2012","journal-title":"Hematology"},{"key":"10.1016\/j.cpt.2024.04.004_bib44","first-page":"2885","article-title":"Management of cardiac toxicity induced by chemotherapy","volume":"9","author":"Trapani","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.cpt.2024.04.004_bib45","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2009.02.050","article-title":"Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management","volume":"53","author":"Yeh","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cpt.2024.04.004_bib46","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1016\/S1470-2045(17)30535-1","article-title":"Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?","volume":"18","author":"Levis","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cpt.2024.04.004_bib47","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2174\/157340311799960654","article-title":"Clinical vignettes: integrated care of cancer patients by oncologists and cardiologists","volume":"7","author":"Hofstatter","year":"2011","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.cpt.2024.04.004_bib48","first-page":"1132","article-title":"Cardiotoxicity of chemotherapy and targeted agents","volume":"11","author":"Mudd","year":"2021","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.cpt.2024.04.004_bib49","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.31557\/APJCP.2021.22.9.2847","article-title":"The role of lisinopril and bisoprolol to prevent anthracycline induced cardiotoxicity in locally advanced breast cancer patients","volume":"22","author":"Wihandono","year":"2021","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"10.1016\/j.cpt.2024.04.004_bib50","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.635144","article-title":"Prevention of high-dose chemotherapy\u2013induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition","volume":"114","author":"Cardinale","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cpt.2024.04.004_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104577","article-title":"Role of cardioprotective agents on chemotherapy-induced heart failure: a systematic review and network meta-analysis of randomized controlled trials","volume":"151","author":"Li","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.cpt.2024.04.004_bib52","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejphar.2010.09.085","article-title":"Cisplatin-induced cardiotoxicity: mechanisms and cardioprotective strategies","volume":"650","author":"El-Awady","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cpt.2024.04.004_bib53","first-page":"147","article-title":"Ameliorating effect of DL-\u03b1-lipoic acid against cisplatin-induced nephrotoxicity and cardiotoxicity in experimental animals","volume":"6","author":"Hussein","year":"2012","journal-title":"Drug Discov Ther"},{"key":"10.1016\/j.cpt.2024.04.004_bib54","article-title":"Antioxidant effect of acetyl-l-carnitine against cisplatin-induced cardiotoxicity","volume":"48","author":"Bayrak","year":"2020","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.cpt.2024.04.004_bib55","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/biof.1301","article-title":"Taurine protects cisplatin induced cardiotoxicity by modulating inflammatory and endoplasmic reticulum stress responses","volume":"42","author":"Chowdhury","year":"2016","journal-title":"Biofactors"},{"key":"10.1016\/j.cpt.2024.04.004_bib56","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cbi.2013.11.008","article-title":"Exploring the protective role of apocynin, a specific NADPH oxidase inhibitor, in cisplatin-induced cardiotoxicity in rats","volume":"207","author":"El-Sawalhi","year":"2014","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.cpt.2024.04.004_bib57","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s12012-021-09636-3","article-title":"The effect of curcumin nanoparticles on cisplatin-induced cardiotoxicity in male Wistar albino rats","volume":"21","author":"Khadrawy","year":"2021","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.cpt.2024.04.004_bib58","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.acthis.2019.04.013","article-title":"The influence of ginger administration on cisplatin-induced cardiotoxicity in rat: light and electron microscopic study","volume":"121","author":"El-Hawwary","year":"2019","journal-title":"Acta Histochem"},{"key":"10.1016\/j.cpt.2024.04.004_bib59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.31351\/vol21iss1pp27-33","article-title":"Protective effect of ginger extract against cisplatin-induced hepatotoxicity and cardiotoxicity in rats","volume":"21","author":"Attyah","year":"2012","journal-title":"Iraqi J Pharm Sci"},{"key":"10.1016\/j.cpt.2024.04.004_bib60","first-page":"423","article-title":"The effects of N-acetylcysteine on cisplatin induced cardiotoxicity","volume":"120","author":"Gunturk","year":"2019","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.cpt.2024.04.004_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154331","article-title":"Icariin exhibits protective effects on cisplatin-induced cardiotoxicity via ROS-mediated oxidative stress injury in vivo and in vitro","volume":"104","author":"Xia","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cpt.2024.04.004_bib62","first-page":"1959","article-title":"Cyanidin ameliorates cisplatin-induced cardiotoxicity via inhibition of ROS-mediated apoptosis","volume":"15","author":"Qian","year":"2018","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.cpt.2024.04.004_bib63","first-page":"675","article-title":"Resveratrol protects against cisplatin-induced cardiotoxicity by alleviating oxidative damage","volume":"24","author":"Wang","year":"2009","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.cpt.2024.04.004_bib64","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s10741-015-9502-y","article-title":"Chemotherapy-induced cardiomyopathy","volume":"20","author":"Higgins","year":"2015","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cpt.2024.04.004_bib65","first-page":"149","article-title":"The cardiotoxicity of chemotherapy: new prospects for an old problem","volume":"40","author":"Miolo","year":"2006","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.cpt.2024.04.004_bib66","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.cjca.2014.04.029","article-title":"Chemotherapy-induced cardiotoxicity: detection, prevention, and management","volume":"30","author":"Truong","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cpt.2024.04.004_bib67","series-title":"Anti-cancer treatments and cardiotoxicity","first-page":"329","article-title":"Chapter 28 \u2013 nonpharmacologic therapy","author":"Salinas","year":"2017"},{"key":"10.1016\/j.cpt.2024.04.004_bib68","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2217\/nnm-2020-0199","article-title":"Nano liposomal and cubosomal formulations with platinum-based anticancer agents: therapeutic advances and challenges","volume":"15","author":"Alavi","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.cpt.2024.04.004_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.847012","article-title":"Cardiotoxicity of anticancer drugs: molecular mechanisms and strategies for cardioprotection","volume":"9","author":"Morelli","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cpt.2024.04.004_bib70","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s12265-020-10042-3","article-title":"The role of biomarkers in cardio-oncology","volume":"13","author":"Ananthan","year":"2020","journal-title":"J\u00a0Cardiovasc Transl Res"},{"key":"10.1016\/j.cpt.2024.04.004_bib71","doi-asserted-by":"crossref","first-page":"64","DOI":"10.15420\/ecr.2017:17:2","article-title":"Cardio-oncology: a focus on cardiotoxicity","volume":"13","author":"Koutsoukis","year":"2018","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.cpt.2024.04.004_bib72","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.taap.2013.09.017","article-title":"Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicity","volume":"273","author":"Sirenko","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.cpt.2024.04.004_bib73","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.3390\/cells10112823","article-title":"Cardiotoxicity of antineoplastic therapies and applications of induced pluripotent stem cell-derived cardiomyocytes","volume":"10","author":"Huang","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.cpt.2024.04.004_bib74","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/cvr\/cvz024","article-title":"Personalized medicine in cardio-oncology: the role of induced pluripotent stem cell","volume":"115","author":"Sayed","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cpt.2024.04.004_bib75","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010189","article-title":"Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase","volume":"6","author":"Liu","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cpt.2024.04.004_bib76","first-page":"8","article-title":"Zebrafish models of cancer therapy-induced cardiovascular toxicity","volume":"8","author":"Lane","year":"2021","journal-title":"J\u00a0Cardiovasc Dev Dis"},{"key":"10.1016\/j.cpt.2024.04.004_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112695","article-title":"Pharmacological assessment of zebrafish-based cardiotoxicity models","volume":"148","author":"Maciag","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.cpt.2024.04.004_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111375","article-title":"Calycosin attenuates doxorubicin-induced cardiotoxicity via autophagy regulation in zebrafish models","volume":"137","author":"Lu","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.cpt.2024.04.004_bib79","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3389\/fphys.2017.00668","article-title":"Human in silico drug trials demonstrate higher\u00a0accuracy than animal models in predicting clinical pro-arrhythmic cardiotoxicity","volume":"8","author":"Passini","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.cpt.2024.04.004_bib80","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.3390\/cells11071090","article-title":"Integrative computational modeling of cardiomyocyte calcium handling and cardiac arrhythmias: current status and future challenges","volume":"11","author":"Sutanto","year":"2022","journal-title":"Cells"}],"container-title":["Cancer Pathogenesis and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713224000284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713224000284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T08:03:26Z","timestamp":1741853006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949713224000284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2949713224000284"],"URL":"https:\/\/doi.org\/10.1016\/j.cpt.2024.04.004","relation":{},"ISSN":["2949-7132"],"issn-type":[{"value":"2949-7132","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiotoxicity in platinum-based chemotherapy: Mechanisms, manifestations, and management","name":"articletitle","label":"Article Title"},{"value":"Cancer Pathogenesis and Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpt.2024.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of Chinese Medical Association (CMA).","name":"copyright","label":"Copyright"}]}}